NCT04788030

Brief Summary

Muscle-in-vein conduits (MVCs) provide an alternative for bridging digital nerve defects when tension-free suture is not possible. Low donor site morbidity and absence of additional costs are favorable advantages compared to autografts or conduits. 37 patients with 43 defects of proper palmar digital nerves were retrospectively enrolled. Primary repair by MVCs was performed in 22 cases while 21 underwent secondary reconstruction. Recovery of sensibility was assessed by static and moving two-point discrimination (2PDs, 2PDm) and Semmes-Weinstein monofilaments (SWM). Results were compared with contralateral side serving as intraindividual control. Outcome data were stratified according to international guidelines and evaluated for differences in terms of age, gap length, time of reconstruction and concomitant injuries.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2008

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

February 19, 2021

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 9, 2021

Completed
Last Updated

March 9, 2021

Status Verified

March 1, 2021

Enrollment Period

10 years

First QC Date

February 19, 2021

Last Update Submit

March 4, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Two-point discrimination

    Six months after reconstruction or later

  • Semmes-Weinstein-Monofilament test

    Six months after reconstruction or later

Secondary Outcomes (4)

  • Age

    Baseline

  • Gap length

    Baseline

  • Time of reconstruction

    Baseline

  • Concomitant injuries

    Baseline

Study Arms (1)

Digital nerve reconstruction with muscle-in-vein conduits

Other: Nerve reconstruction

Interventions

Nerve bridging with muscle-in-vein conduits

Digital nerve reconstruction with muscle-in-vein conduits

Eligibility Criteria

Age6 Years - 72 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The mean age of all patients was 38.0 years (SD 18.4, range 6-72). All patients aged younger than 18 years were males whereas patients older than 60 years tend to be females.

You may qualify if:

  • \- Patients with reconstruction of digital nerves with muscle-in-vein conduits

You may not qualify if:

  • Subtotal or total amputations
  • pre-existing neurological disorders (e.g. polyneuropathy)
  • symptoms of nerve entrapment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of the Department of Hand, Plastic and Aesthetic Surgery, medius Hospital Nürtingen

Study Record Dates

First Submitted

February 19, 2021

First Posted

March 9, 2021

Study Start

January 1, 2008

Primary Completion

December 31, 2017

Study Completion

January 31, 2021

Last Updated

March 9, 2021

Record last verified: 2021-03